NEUROPATHOLOGY CORE
神经病理学核心
基本信息
- 批准号:7624799
- 负责人:
- 金额:$ 30.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAge of OnsetAllelesAlzheimer&aposs DiseaseApolipoprotein EAtrophicAutopsyBiocompatible MaterialsBiological MarkersBloodBlood specimenBrainBrain regionCaliforniaChillsClinicalCodeCollaborationsCreutzfeldt-Jakob SyndromeDNADataDatabasesDegenerative DisorderDementiaDendritesDiagnosisDiagnosticDiseaseDissectionEnrollmentEnvironmentExcisionFactor AnalysisFosteringFreezingFrontotemporal Lobar DegenerationsGenesGeneticGenetic DatabasesGenetic MaterialsGenomicsGenotypeGlial Fibrillary Acidic ProteinGoalsGraphHeterogeneityHippocampus (Brain)HistologyHumanHuman ResourcesImageImmersion Investigative TechniqueInstitutionInstructionLaboratoriesLeadMaintenanceMeasurementMedical centerMethodsMicroscopicMissionMolecularMolecular GeneticsMotor Neuron DiseaseNerve DegenerationNeurologistNeuronsNeurosciencesOther GeneticsPathologyPatientsPennsylvaniaPrPSc ProteinsPresynaptic TerminalsPrincipal InvestigatorProgressive Supranuclear PalsyProteomicsProtocols documentationPublicationsPublishingQualifyingRadialRecruitment ActivityReportingResearchResearch PersonnelResearch TrainingResourcesRiskSamplingSan FranciscoScientistSclerosisSecureSequence AnalysisServicesSingle Nucleotide PolymorphismSliceSlideSpecimenSpinal CordStaining methodStainsSynaptophysinTestingTimeTissuesUbiquitinUniversitiesUpdateWritingalpha synucleinbasebrain tissueclinical Diagnosiscohortcorticobasal degenerationdigitaldigital imagingdopaminergic neurongenetic analysisgenetic risk factorinterdisciplinary collaborationinterestmorphometrymultidisciplinaryneuropathologynovelnovel strategiesparaformpresenilin-1protein TDP-43research studytau Proteinstissue processing
项目摘要
Core D, the Neuropathology Core (NP Core), is a continuation of the same core that has served the ADRC
for the past 4 years. The personnel are the same except for a recently hired histology technician. Because
Dr. Bruce Miller and the Clinical Core have recruited patients with FTDs and atypical dementing disorders
throughout Northern California and beyond, we have hired Glen Oaks Pathology Services (San Francisco) to
remove brains from enrolled patients within a 150 mile radius from UCSF. The chilled brain is transported to
Dr. Eric Huang at the San Francisco VA Medical Center where the first of three brain dissection steps is
performed: Dr. Huang coronally sections the fresh brain and alternate slabs are either immersion fixed in
paraformaldehyde or frozen. Next, the fixed brain slabs are transported to Dr. William Seeley's laboratory at
the UCSF Mission Center Building (MCB). Dr. Seeley has been studying selective neuronal vulnerability in
FTD in close collaboration with Dr. DeArmond and the NP Core. Dr. Seeley dissects brain regions of interest
for his studies and also performs dissections for other ADRC investigators. Finally, the remaining fixed brain
samples are sent to Dr. DeArmond's Lab (adjacent to Dr. Seeley's) for removal of ~30 blocks of tissue for
diagnostic neuropathological analysis. Dr. DeArmond and his staff perform multiple neurohistological and
immunohistochemical stains on the blocks, perform semiquantitiatve analysis of the stained slides, write a
detailed neuropathology final report on each case, and complete a NACC form. The NP Core provides
quality digital photographs and quantitative morphometric analysis of neuropathological changes as needed
for publications. The overall aim of this ADRC is to better understand the clinical heterogeneity of patients
with AD, FTD and related disorders, and to tackle the problem of selective vulnerability. Complimentary to
the clinical aim, the overall aim of the NP Core is to better understand the overlap of multiple different
clinically and neuropathologically defined entities we are finding in many dementia patients. Through a
consortium arrangement with Dr. Daniel Geschwind at UCLA, the NP Core will oversee transport of blood
samples to his lab for differential genetic analysis of heterogeneity.
RELEVANCE (See instructions):
This core will provide a unique resource to dementia neuroscience investigators at the UCSF ADRC and
beyond by systematically banking brain tissue and genetic materials from patients with AD, FTD, and other
dementias. These resources are intended to facilitate modern neuroscientific research studies related to
these disorders that will ultimately lead to new treatments.
核心D,神经病理学核心(NP核心),是为ADRC服务的相同核心的延续
在过去的四年中。除最近雇用的组织学技术人员外,人员是相同的。因为
布鲁斯·米勒(Bruce Miller)博士和临床核心已招募了FTD和非典型痴呆症患者
在整个北加州及其他地区,我们聘请了Glen Oaks病理学服务(旧金山)
从UCSF半径150英里内,从注册患者中清除大脑。冷藏大脑被运输到
旧金山弗吉尼亚州医疗中心的埃里克·黄博士在三个大脑解剖中的第一个是
进行的:黄冠冕博士的新鲜大脑和替代板固定在
多聚甲醛或冷冻。接下来,将固定的脑板运送到William Seeley博士的实验室
UCSF任务中心大楼(MCB)。 Seeley博士一直在研究选择性神经元脆弱性
FTD与Dearmond博士和NP Core密切合作。 Seeley博士剖析了感兴趣的大脑区域
为了他的学习,还为其他ADRC研究人员进行解剖。最后,剩余的固定大脑
样品被发送到迪尔蒙德博士的实验室(靠近Seeley博士),以取消约30个块的组织
诊断神经病理分析。迪尔蒙德博士和他的员工进行多种神经组织学和
块上的免疫组织化学染色,对彩色幻灯片进行半定位分析,写一个
详细的关于每种情况的神经病理学最终报告,并填写NACC表格。 NP核心提供
根据需要
出版物。该ADRC的总体目的是更好地了解患者的临床异质性
使用AD,FTD和相关疾病,并解决选择性脆弱性的问题。补充
临床目的,NP核心的总体目的是更好地了解多个不同的重叠
我们在许多痴呆症患者中发现的临床和神经病理学定义的实体。通过一个
与UCLA的Daniel Geschwind博士的财团安排,NP核心将监督血液的运输
样品到他的实验室进行异质性差异遗传分析。
相关性(请参阅说明):
该核心将为UCSF ADRC和
除了系统地将AD,FTD患者和其他患者的脑组织和遗传材料融为一体之外
痴呆症。这些资源旨在促进与现代神经科学研究研究
这些疾病最终会导致新治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen J. DeArmond其他文献
Stephen J. DeArmond的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen J. DeArmond', 18)}}的其他基金
相似国自然基金
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
晶状体mtDNA氧化损伤修复与线粒体自噬的空间差异及其调控干预在年龄相关性白内障发病中的作用
- 批准号:82171038
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
FoxO3a通路抑制在年龄相关性白内障发病机制中的调控作用
- 批准号:82070942
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
肠道微生态参与年龄相关性黄斑变性的发病机制及固本清目方的干预作用
- 批准号:81973912
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
ODRP泛素化经LECs外泌体释放和自噬降解调控年龄相关性白内障的发病
- 批准号:81974129
- 批准年份:2019
- 资助金额:57 万元
- 项目类别:面上项目
相似海外基金
Upregulation of progranulin in a human iPSC-derived neurovascular model of GRN-associated Frontotemporal Dementia
GRN 相关额颞叶痴呆的人 iPSC 衍生神经血管模型中颗粒体蛋白前体的上调
- 批准号:
10789724 - 财政年份:2023
- 资助金额:
$ 30.84万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 30.84万 - 项目类别:
The predicative values of vascular and metabolic disorders for risk of incident mild cognitive impairment and dementia
血管和代谢紊乱对发生轻度认知障碍和痴呆风险的预测价值
- 批准号:
10661996 - 财政年份:2023
- 资助金额:
$ 30.84万 - 项目类别:
The effects of APOE genotype in homeostatic microglial function in preclinical APOE mouse model
APOE基因型对临床前APOE小鼠模型稳态小胶质细胞功能的影响
- 批准号:
10828613 - 财政年份:2023
- 资助金额:
$ 30.84万 - 项目类别:
RLIP, Mitochondrial Dysfunction in Alzheimer’s Disease
RLIP,阿尔茨海默病中的线粒体功能障碍
- 批准号:
10901025 - 财政年份:2023
- 资助金额:
$ 30.84万 - 项目类别: